EP Patent

EP3560929A2 — Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same

Assigned to Shionogi and Co Ltd · Expires 2019-10-30 · 7y expired

What this patent protects

The present invention relates to a process for preparing a compound of the formula (II):wherein R<sup>1b</sup>is a hydroxy-protecting group, R<sup>2</sup>is optionally substituted lower alkyl, and R<sup>3</sup>is optionally substituted lower al…

USPTO Abstract

The present invention relates to a process for preparing a compound of the formula (II):wherein R<sup>1b</sup>is a hydroxy-protecting group, R<sup>2</sup>is optionally substituted lower alkyl, and R<sup>3</sup>is optionally substituted lower alkyl, optionally substituted cycloalkyl, substituted or non-substituted aryl or substituted or non-substituted heteroaryl, characterized by reacting a compound of the formula (III):wherein R<sup>1b</sup>and R<sup>2</sup>are the same as defined above, in the presence or absence of an acid with a compound of the formula: R<sup>3</sup>-N=C=O , wherein R<sup>3</sup>is the same as defined above, or with a compound of the formula: R<sup>3</sup>-NH-C(=O)-X, wherein R<sup>3</sup>is the same as defined above and X is a leaving group.

Drugs covered by this patent

Patent Metadata

Patent number
EP3560929A2
Jurisdiction
EP
Classification
Expires
2019-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.